atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial

/PRNewswire/ -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today...

Related Keywords

United States ,France ,Switzerland ,Sept Occluder ,Laurent Grandidier ,Katie Arnold ,University Of Virginia ,Company Data On File ,Heart Medical ,Device Exemption ,Scott Lim ,Trial Identifier ,Atheart Medical ,